Virtual Reality for Anxiety Relief in Infertile Women
Launched by CYPRUS AYDIN UNIVERSITY · Jun 12, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This doctoral study aims to evaluate the use of virtual reality (VR) as an innovative, non-invasive intervention for managing anxiety during embryo transfer in assisted reproductive technology (ART). A randomized clinical trial will be conducted with 80 participants, aged 18 to 50, undergoing fertility treatment at a healthcare facility in the Turkish Republic of Northern Cyprus (TRNC).
Participants will be randomly assigned to one of two groups: the intervention group (n=40), which will experience a VR session both before and after the embryo transfer, and the control group (n=40), which ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Volunteered to participate in the research,
- • 18-50 years old
- • No vision and hearing problems,
- • Not disoriented in time and place,
- • Primary infertile
- • Not having communication problem
- • Can read \& write
- • No mental pathological disease
- Exclusion Criteria:
- • Secondary infertility
- • Having experienced bleeding, miscarriage, etc. after embryo transfer,
- • Difficulty communicating,
- • Problems such as migraine, vertigo, dizziness,
- • Patients who wear prescription glasses and have vision problems without glasses
- • Refused to participate in the research
- • Patients with psychiatric pathology
About Cyprus Aydin University
Cyprus Aydin University is a dynamic educational institution committed to advancing research and innovation in the fields of health sciences and beyond. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking research initiatives aimed at improving patient outcomes and enhancing medical knowledge. With a focus on ethical practices and rigorous scientific methodologies, Cyprus Aydin University collaborates with a diverse range of stakeholders, including healthcare professionals and industry partners, to ensure the successful execution of clinical trials that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Girne Kepuveia, Girne, Cyprus
Patients applied
Trial Officials
NAZLI CATAK, MSc
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported